Baxter beats by $0.06, reports revs in-line; guides Q3 EPS above consensus, revs above consensus; raises FY17 EPS above consensus, revs above consensus (62.09)
- Reports Q2 (Jun) earnings of $0.63 per share, excluding non-recurring items, $0.06 better than the Capital IQ Consensus of $0.57; revenues rose 0.8% year/year to $2.61 bln vs the $2.59 bln Capital IQ Consensus.
- Co issues upside guidance for Q3, sees EPS of $0.58-0.60 vs. $0.56 Capital IQ Consensus Estimate; sees Q3 revs growth of 6% YoY, which calculates to ~$2.71 bln vs. $2.59 bln Capital IQ Consensus Estimate.
- Co raises guidance for FY17, sees EPS of $2.34-2.40, excluding non-recurring items, up from $2.20-2.28, vs. $2.27 Capital IQ Consensus Estimate; sees FY17 revs growth of 5%, which calculates to ~$10.67 bln vs. $10.37 bln Capital IQ Consensus Estimate